日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Outcomes at 3 Years in 82 Knees with Kellgren and Lawrence 2-3 Osteoarthritis Treated with an Autologous Protein Fluid Concentrate Produced with a Fluid Volume Reducer

82例Kellgren-Lawrence 2-3级骨关节炎膝关节采用自体蛋白浓缩液(使用液体容量减少器制备)治疗3年后的结果

Sheinkop, Mitchell; Langhenry, Mary; Abd-Elsayed, Alaa

Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis

对符合现行良好生产规范 (cGMP) 的中央实验室生产的自体脂肪来源基质血管成分细胞疗法产品治疗膝骨关节炎的安全性和有效性进行临床评价

Rogers, Christopher J; Harman, Robert; Sheinkop, Mitchell B; Hanson, Peter; Ambach, Mary A; David, Tal; Desai, Rahul; Sampson, Steven; Aufierro, Danielle; Bowen, Jay; Malanga, Gerard

A specific protocol of autologous bone marrow concentrate and platelet products versus exercise therapy for symptomatic knee osteoarthritis: a randomized controlled trial with 2 year follow-up

自体骨髓浓缩物和血小板制品特定方案与运动疗法治疗症状性膝骨关节炎的比较:一项为期2年的随机对照试验

Centeno, Christopher; Sheinkop, Mitchell; Dodson, Ehren; Stemper, Ian; Williams, Christopher; Hyzy, Matthew; Ichim, Thomas; Freeman, Michael